Big Pharma companies urge Irish government to oppose new EU law to increase competition

  • 📰 businessposthq
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 71%

United States News News

United States United States Latest News,United States United States Headlines

Pharma companies are unhappy with European Commission’s plan to slash the amount of time between the launch of a new drug and a rival firm being able to build a competitor

Global pharmaceutical companies have urged the Irish government to oppose new EU laws that will slash the amount of time between the launch of a new drug and rival firms being able to develop competing products.

The global chief executives of 27 companies wrote to Taoiseach Leo Varadkar in March raising concern over the proposals, which are the first major overhaul of the EU’s medicines regulations in 20 years and aim to make access to ...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 8. in US

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Big Pharma companies urge Irish government to oppose new EU law to increase competitionPharma companies are unhappy with European Commission’s plan to slash the amount of time between the launch of a new drug and a rival firm being able to build a competitor
Source: businessposthq - 🏆 8. / 71 Read more »

Big Pharma companies urge Irish government to oppose new EU law to increase competitionGlobal pharmaceutical companies have urged the Irish government to oppose new EU laws that will slash the amount of time between the launch of a new drug and rival firms being able to develop competing products.
Source: businessposthq - 🏆 8. / 71 Read more »